BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
VEGFA
,
T cell receptor signaling pathway
,
Breast Cancer
,
Embryo
,
Biofuel
,
Prozac
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
folic acid
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Broad Connectivity Map (CMAP 2.0) compound database
Drug target sets for approved compounds
B-cell lymphoma cell lines treated by 92 FDA approved compounds - a timecourse
Explore Curated Studies Results
Literature
Most Relevant Literature
Nanoparticles mediated folic acid enrichment.
Folic acid: friend or foe in cancer therapy.
Surface Modification of Liposomes Using Folic Acid.
Direct Immobilization of Folic Acid Molecules on Hydroxyapatite Nanoparticles with Substitution and …
Mendelian randomization to evaluate the effect of folic acid supplement on the risk of Alzheimer dis…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Optimizing Periconceptional and Prenatal Folic Acid Supplementation
Folic Acid in Pediatric Inflammatory Bowel Disease
Folic Acid Intervention During Recovery
Evaluation of Mirtazapine and Folic Acid for Schizophrenia:
Folic Acid Supplementation in Children With Sickle Cell Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ